Akademska digitalna zbirka SLovenije - logo
E-viri
Recenzirano Odprti dostop
  • Combined treatment of drug-...
    Pontali, Emanuele; Sotgiu, Giovanni; Tiberi, Simon; Tadolini, Marina; Visca, Dina; D'Ambrosio, Lia; Centis, Rosella; Spanevello, Antonio; Migliori, Giovanni Battista

    The European respiratory journal, 07/2018, Letnik: 52, Številka: 1
    Journal Article

    The World Health Organization (WHO) estimated that 490 000 cases of multidrug-resistant (MDR) tuberculosis (TB) (defined as TB caused by Mycobacterium tuberculosis strains resistant to at least isoniazid and rifampicin) occurred in 2016. Among them, ∼6.2% had extensively drug-resistant (XDR) TB (i.e. TB caused by MDR strains with additional resistance to fluoroquinolones and at least one second-line injectable drug) 1.